| Name | Title | Contact Details |
|---|---|---|
Susan Eckman |
Associate General Counsel | Profile |
JNetDirect - Middleware Connectivity and Code Management for All Versions of Microsoft SQL Server
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Syntergy is a La Jolla, CA-based company in the Software and Internet sector.
Oklahoma (/ˌoʊkləˈhoʊmə/) is a state in the South Central region of the United States, bordered by the state of Texas on the south and west, Kansas on the north, Missouri on the northeast, Arkansas on the east, New Mexico on the west, and Colorado on t...